Abcam PLC | Income Statement

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
122,206.00
127,954.00
144,033.00
171,673.00
217,098.00
233,200
Cost of Goods Sold (COGS) incl. D&A
39,338.00
42,400.00
47,611.00
58,618.00
74,711.00
78,600
Gross Income
82,868.00
85,554.00
96,422.00
113,055.00
142,387.00
154,600
SG&A Expense
39,620.00
43,446.00
50,695.00
64,201.00
93,776.00
90,000
EBIT
43,248.00
43,112.00
-
48,854.00
48,611.00
64,600
Unusual Expense
400.00
201.00
-
500.00
4,274.00
200
Non Operating Income/Expense
83.00
-
-
3,088.00
7,375.00
900
Pretax Income
42,894.00
43,551.00
46,099.00
45,412.00
51,874.00
66,000
Income Tax
10,236.00
9,506.00
8,715.00
7,983.00
9,517.00
3,800
Consolidated Net Income
32,658.00
34,045.00
37,384.00
37,429.00
42,357.00
62,200
Net Income
32,658.00
34,045.00
37,384.00
37,429.00
42,357.00
62,200
Net Income After Extraordinaries
32,658.00
34,045.00
37,384.00
37,429.00
42,357.00
62,200
Net Income Available to Common
32,658.00
34,045.00
37,384.00
37,429.00
42,357.00
62,200
EPS (Basic)
0.17
0.17
0.19
0.19
0.21
0.31
Basic Shares Outstanding
197,743.40
198,858.30
199,979.00
201,147.90
202,655.30
204,200
EPS (Diluted)
0.16
0.17
0.19
0.19
0.21
0.30
Diluted Shares Outstanding
199,919.90
200,018.20
201,277.50
202,002.90
204,223.90
205,800
EBITDA
49,076.00
49,825.00
53,765.00
60,209.00
63,937.00
77,500
Other Operating Expense
-
1,004.00
-
-
-
-
Non-Operating Interest Income
129.00
238.00
372.00
146.00
162.00
300

About Abcam

View Profile
Address
330 Cambridge Science Park
Cambridge East Anglia CB4 0FL
United Kingdom
Employees -
Website http://abcam.com
Updated 07/08/2019
Abcam Plc distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. The company was founded by Adam Robert David Cleevely, Anthony Kouzarides and Jonathan Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.